Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 ,inter alia, to consider and approve Audited Standalone Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenotech Laboratories has informed BSE that its Board of Directors will meet on Friday, April 25, 2025, to consider and approve the audited standalone financial results for the quarter and financial year ended March 31, 2025. This is a routine regulatory filing under SEBI's Listing Obligations and Disclosure Requirements. The company has also confirmed that the trading window for its securities remains closed from April 1, 2025, until April 27, 2025, which is 48 hours after the results are declared. No financial figures or outcomes have been disclosed at this stage.
This is a procedural announcement with no immediate impact on the stock. Investors should watch for the actual audited results on April 25, 2025, which will provide key insights into the company's FY25 performance.